Nanomedicine News

RSS

Graphene-Based Nanozymes can be Used to Identify L-Cysteine in Serum

Graphene-Based Nanozymes can be Used to Identify L-Cysteine in Serum

Graphene-based materials can be obtained using various reducing agents, many of which are dangerous and toxic chemicals, and the obtained graphene-based materials are prone to aggregation, limiting their practical applications.

2 Jun 2021

Polymeric Nanoparticles Deliver Dopamine to Parkinson’s-Affected Rat Brain

Polymeric Nanoparticles Deliver Dopamine to Parkinson’s-Affected Rat Brain

Parkinson’s disease (PD) is a general neurodegenerative disorder that occurs due to the death of dopaminergic neurons in a part of the brain (called substantia nigra pars compacta), which results in a lack of dopamine (DA), one of the principal neurotransmitters active in the central nervous system.

2 Jun 2021

Dolomite Microfluidics and Phosphorex Partner to Accelerate Lipid Nanoparticle Development in the Fields of Drug Delivery and Nanomedicine

Dolomite Microfluidics and Phosphorex Partner to Accelerate Lipid Nanoparticle Development in the Fields of Drug Delivery and Nanomedicine

Dolomite Microfluidics, a leading developer of particle systems for drug delivery, and Phosphorex, Inc., a leading contract development and manufacturing organization specializing in particle-based formulation of drug products, are pleased to announce their partnership to establish unique capabilities in drug and vaccine development.

From Phosphorex, Inc. 2 Jun 2021

Study Shows Peptide Nanoparticles can be Used for In Vitro Visualization

Study Shows Peptide Nanoparticles can be Used for In Vitro Visualization

A collaborative study by Kazan Federal University and Chinese Academy Sciences has been reported in Chemical Engineering Journal.

31 May 2021

Inhalable Nanobodies can Treat Severe COVID-19 Infection

Inhalable Nanobodies can Treat Severe COVID-19 Infection

Scientists from the University of Pittsburgh School of Medicine have demonstrated that inhalable nanobodies can prevent and cure severe COVID-19 in hamsters by targeting the spike protein of the SARS-CoV-2 coronavirus.

27 May 2021

New Stiffened Graphene Could Pave Way for Novel Applications

New Stiffened Graphene Could Pave Way for Novel Applications

The ultrathin material graphene is defined by its extremely small bending modulus—superflimsiness.

26 May 2021

Preclinical Trials Demonstrate the Efficacy of Nanoparticle-Based Vaccine

Preclinical Trials Demonstrate the Efficacy of Nanoparticle-Based Vaccine

Preclinical studies have demonstrated the effectiveness of an experimental flu vaccine that contains scores of microscopic spherical sacs carrying infection-fighting proteins all through the body.

25 May 2021

New Method Using Chemically-Sensitive "Soft" X-Rays Sheds More Light on Nanocarriers

New Method Using Chemically-Sensitive "Soft" X-Rays Sheds More Light on Nanocarriers

Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.

25 May 2021

Nanopore Sequencing Technology can Improve Quality and Accuracy of Biological Data

Nanopore Sequencing Technology can Improve Quality and Accuracy of Biological Data

A new software tool developed by Earlham Institute researchers will help bioinformaticians improve the quality and accuracy of their biological data, and avoid mis-assemblies.

20 May 2021

Combination of Blue-Green Algae and Nanoparticles Shows Promise for Treating Strokes

Combination of Blue-Green Algae and Nanoparticles Shows Promise for Treating Strokes

Blocked blood vessels in the brains of stroke patients prevent oxygen-rich blood from getting to cells, causing severe damage. Plants and some microbes produce oxygen through photosynthesis.

20 May 2021

Previous
1
...
57
58
59
60
61
62
63
...
554
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.